Current Report Filing (8-k)
27 Septiembre 2017 - 5:08AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
September 27, 2017
Date of report (date of earliest event reported)
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-37415
|
|
32-0454912
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
800 N. Glebe Road, Suite 500, Arlington, Virginia 22203
(Address of principal executive offices)(zip code)
(571) 389-6000
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following circumstances:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
ý
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
ý
Item 8.01 – Other Events.
On September 27, 2017, Evolent Health, Inc. announced that it has entered into an agreement to acquire assets related to the small group, large group and ASO commercial business from New Mexico Health Connections (“NMHC”) to establish a new health plan managed services organization. The transaction is subject to customary closing conditions which include certain regulatory approvals, including approval by the New Mexico Office of Superintendent of Insurance.
A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference (other than paragraphs one through five thereof).
Item 9.01 – Financial Statements and Exhibits
(d) Exhibits
The following documents are filed as exhibits to this report:
Exhibit
Number
|
|
Description of Exhibit
|
|
|
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
EVOLENT HEALTH, INC.
|
|
|
|
|
|
|
|
|
|
Date: September 27, 2017
|
By:
|
/s/ Jonathan Weinberg
|
|
|
|
Name: Jonathan Weinberg
|
|
|
|
Title: General Counsel and Secretary
|
|
|
|
|
|
EXHIBIT INDEX
Exhibit
Number
|
|
Description of Exhibit
|
|
|
|
|
|
|
Evolent Health (NYSE:EVH)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024
Evolent Health (NYSE:EVH)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024